[Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
The number of invasive group A streptococcal infections have been increasing in the last years. Toxic Shock-like Syndrome due to infections with streptococci (TSLS) is a serious condition still associated with a mortality rate of 30% despite proper treatment. Early diagnosis is difficult and early treatment is important. A typical case of TSLS in a previously healthy 33 year-old woman treated with clindamycin is reported. Penicillin is still the drug of choice for most Group A streptococcal infections, but in fulminant infections failure has been described. Clindamycin is a good choice in complicated infections.
Nørgaard
M
M
Medicinsk afdeling, Sønderborg Sygehus.
D000328:Adult; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D012772:Shock, Septic / Q000188:drug therapy / Q000382:microbiology*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes / Q000187:drug effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002981:Clindamycin
Toksisk shock-lignende syndrom udløst af streptokokker--behandlet med clindamycin.